Your browser is no longer supported. Please, upgrade your browser.
Settings
TBIO Translate Bio, Inc. daily Stock Chart
TBIO [NASD]
Translate Bio, Inc.
Index- P/E- EPS (ttm)-1.74 Insider Own18.09% Shs Outstand60.01M Perf Week-10.68%
Market Cap1.12B Forward P/E- EPS next Y-1.67 Insider Trans-36.16% Shs Float56.32M Perf Month11.25%
Income-94.40M PEG- EPS next Q-0.43 Inst Own81.20% Short Float3.29% Perf Quarter82.58%
Sales11.00M P/S101.57 EPS this Y-1.70% Inst Trans2.09% Short Ratio1.18 Perf Half Y132.00%
Book/sh2.38 P/B7.31 EPS next Y-7.70% ROA-29.20% Target Price30.29 Perf Year51.17%
Cash/sh2.42 P/C7.20 EPS next 5Y- ROE-63.60% 52W Range6.80 - 28.09 Perf YTD113.76%
Dividend- P/FCF- EPS past 5Y- ROI-75.10% 52W High-37.77% Beta-
Dividend %- Quick Ratio4.10 Sales past 5Y- Gross Margin- 52W Low157.06% ATR2.35
Employees93 Current Ratio4.10 Sales Q/Q213.30% Oper. Margin- RSI (14)49.85 Volatility8.96% 9.50%
OptionableYes Debt/Eq0.00 EPS Q/Q67.70% Profit Margin- Rel Volume1.21 Prev Close17.40
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.57M Price17.48
Recom1.60 SMA20-1.04% SMA503.58% SMA20060.21% Volume711,544 Change0.46%
Jul-07-20Reiterated H.C. Wainwright Buy $18 → $32
Jul-06-20Initiated William Blair Outperform
Jun-26-20Initiated SunTrust Buy $40
Jul-22-19Initiated Jefferies Buy $20
Jun-18-19Initiated ROTH Capital Buy $25
Dec-24-18Initiated H.C. Wainwright Buy $21
Jul-23-18Initiated Leerink Partners Outperform $24
Jul-23-18Initiated Evercore ISI Outperform $25
Jul-23-18Initiated Citigroup Buy $20
Jul-02-20 10:38PM  
Jul-01-20 06:03PM  
10:35AM  
Jun-29-20 08:49AM  
Jun-25-20 11:15PM  
09:36PM  
03:26PM  
07:02AM  
Jun-24-20 04:18PM  
09:33AM  
09:29AM  
Jun-23-20 02:38PM  
01:42PM  
11:40AM  
10:38AM  
10:28AM  
07:57AM  
06:21AM  
03:57AM  
01:48AM  
01:21AM  
12:59AM  
Jun-14-20 08:24PM  
11:16AM  
Jun-03-20 11:41AM  
May-28-20 07:30AM  
May-14-20 11:51AM  
08:47AM  
May-12-20 04:05PM  
May-08-20 06:16PM  
May-07-20 04:26PM  
12:30PM  
Apr-26-20 04:55AM  
Apr-20-20 06:12PM  
Apr-17-20 11:35AM  
Apr-14-20 04:41PM  
Mar-30-20 10:41AM  
08:47AM  
Mar-27-20 04:33PM  
04:10PM  
02:20PM  
08:02AM  
02:00AM  
Mar-26-20 04:30PM  
04:30PM  
Mar-12-20 08:35PM  
04:45PM  
12:30PM  
Feb-26-20 07:30AM  
Feb-19-20 07:30AM  
Dec-14-19 05:18PM  
Dec-12-19 04:15PM  
Dec-10-19 12:22PM  
Nov-27-19 09:45AM  
Nov-14-19 11:56AM  
Nov-13-19 07:30AM  
Nov-06-19 07:25PM  
04:11PM  
Oct-31-19 12:15PM  
Oct-30-19 10:56AM  
Oct-01-19 07:30AM  
Sep-30-19 07:30AM  
Sep-24-19 07:14PM  
Sep-23-19 01:16PM  
Sep-17-19 09:06PM  
04:01PM  
Sep-12-19 06:21PM  
04:05PM  
Sep-10-19 01:58PM  
08:27AM  
Sep-09-19 04:05PM  
Aug-30-19 06:57PM  
Aug-21-19 01:38PM  
Aug-16-19 02:51PM  
Aug-04-19 10:03AM  
Jul-31-19 09:55AM  
06:51AM  
Jul-15-19 07:30AM  
Jun-26-19 11:21AM  
07:00AM  
Jun-04-19 06:59AM  
May-28-19 07:30AM  
May-09-19 04:23PM  
May-01-19 07:30AM  
Apr-29-19 08:45AM  
Apr-11-19 07:30AM  
Apr-08-19 04:05PM  
07:30AM  
Apr-01-19 07:30AM  
Mar-26-19 07:30AM  
Mar-25-19 07:30AM  
Mar-21-19 04:29PM  
Mar-18-19 07:30AM  
Mar-04-19 07:30AM  
Feb-27-19 04:30PM  
Feb-14-19 07:30AM  
Jan-24-19 02:30PM  
Jan-22-19 07:30AM  
Jan-04-19 03:26PM  
Jan-03-19 07:30AM  
Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, which is in Phase I/II clinical trial for the treatment of cystic fibrosis; and MRT5201 to treat ornithine transcarbamylase deficiency. It has a collaboration and license agreement with Sanofi Pasteur Inc. to develop mRNA vaccines for up to five infectious diseRaNA Therapeutics, LLCase pathogens, as well as against COVID-19. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017. Translate Bio, Inc. was founded in 2011 and is headquartered in Lexington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shire Human Genetic Therapies,10% OwnerJun 30Sale20.686,824,992141,140,8350Jun 30 08:24 PM
BAUPOST GROUP LLC/MA10% OwnerJun 26Buy22.00500,00011,000,00018,044,239Jun 30 05:37 PM
Shire Human Genetic Therapies,10% OwnerJun 03Sale19.7540,086791,6996,824,992Jun 05 09:52 AM
Shire Human Genetic Therapies,10% OwnerJun 02Sale19.76105,3952,082,9036,865,078Jun 03 06:08 AM
Shire Human Genetic Therapies,10% OwnerJun 01Sale19.86108,4722,154,1216,970,473Jun 03 06:08 AM